Details van artikel 122 van 257 gevonden artikelen
196P Final analysis of PUFFIN: A phase III, randomised double-blind, placebo (Pla)-controlled study of pertuzumab, trastuzumab and docetaxel (PHD) for Chinese patients (pts) with previously untreated HER2-positive locally recurrent or metastatic breast cancer (LR/MBC)
Titel:
196P Final analysis of PUFFIN: A phase III, randomised double-blind, placebo (Pla)-controlled study of pertuzumab, trastuzumab and docetaxel (PHD) for Chinese patients (pts) with previously untreated HER2-positive locally recurrent or metastatic breast cancer (LR/MBC)
Auteur:
Xu, B. Li, W. Zhang, Q. Li, Q. Wang, X. Li, H. Sun, T. Yin, Y. Zheng, H. Feng, J. Zhu, H. Siddiqui, A. Macharia, H.N. Knott, A.
Verschenen in:
Annals of oncology
Paginering:
Jaargang 33 () nr. S3 pagina's S217-S218
Jaar:
2022
Inhoud:
Uitgever:
European Society for Medical Oncology
Bronbestand:
Elektronische Wetenschappelijke Tijdschriften
Details van artikel 122 van 257 gevonden artikelen